Normal fibrinolytic responses to 1 -desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene

Nephron

Volumn 72, Issue 4, 1996, Pages 544-546

  Van Lieburg, A F ^a   Knoers, V V A M ^a   Mallmann, R ^b   Proesmans, W ^c   Van den Heuvel, L P W J ^a   Monnens, L A H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

1 Desamino 8 D< italic> arginine; Aquaporin 2; Nephrogenic diabetes insipidus; Tissue type plasminogen activator; Vasopressin; Vasopressin type 2 receptor

Indexed keywords

AQUAPORIN; DESMOPRESSIN; NEUROHYPOPHYSIS HORMONE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOLYSIS; GENE MUTATION; HEMODYNAMICS; HOT FLUSH; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL; TACHYCARDIA;

ADOLESCENT; ADULT; AQUAPORIN 2; AQUAPORIN 6; AQUAPORINS; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; FIBRINOLYSIS; HUMANS; ION CHANNELS; MALE; MUTATION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0029986834     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188936     Document Type: Article

References (19)

1. Pliska V: Pharmacology of deamino-D-argi-ninc vasopressin; in Czemichow P. Robinson AG (eds): Diabetes insipidus in Man. Front Horn Res Basel. Karger. 1985. vol 13. pp 278-291.
2. Mannucci PM. Aberg M, Nilsson IM. Robertson B: Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. BrJ Haematol 1975:30:81-93.
3. Knoers N. Brommer EJ. Willems H. van Oost BA, Monnens LAH: Fibrinolytic responses to 1-desamino-8-/7-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron 1991;58:372-373.
4. Liard J: Effects ofa specific antidiuretic agonist on cardiac output and its distribution in intact and anephric dogs. Clin Sci 1988:74:293-299.
5. Block LH. Locger R, Tcnschcrt W. Sicgenthaler W. Hofmann T, Mcltler R. Vetter W: βI-8-β-argininc vasopressin binding to human mononuclear phagocytes. J Clin Invest 1981:68:374-381.
6. Hashcmi S. Palmer DS. Ave MT. Ganz PR: Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willcbrand factor release from endothelial cells. J Cell Physiol 1993:154:496-505.
7. Kobrinsky NL. Doyle JJ, Israels ED. Winter JSD. Chcang MS. Walker RD. Bishop AJ: Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus. Lancet 1985;Vol i: 1293-1294.
8. Bichet DG. Razi M. Lonergan M. Arthus M, Papukna V, Kortas C, Barjon J: Hemodynamic and coagulation responses to l-dcsamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988:318:881-887.
9. Brink HS. Dcrkx FHM. Boomsma F. Brommer EJP. Schalckamp MADH: l-Desamino-8-D-ar-ginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus. Neth J Med 1993:43:5-12.
10. Rosenthal W. Seibold A. Antaramian A. Lonergan M. Arthus M. Hendv GN. Birnbaumer M. Bichet DG: Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992:359:233-235.
11. Brenner B. Seligsohn U. Hochbcrg Z: Normal response of factor VIII and von Willcbrand factor to l-deamino-8/J-arginine vasopressin in nephrogenic diabetes insipidus. J Clin Endocrinol Metab 1988:67:191-193.
12. Knoers N, Monnens LAH: A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr 1991:150:370-373.
13. Langley JM. Balfc JW, Sclander T. Ray PN. Clarke JTR: Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet 1991;38:90-94.
14. Fushimi K. Uchida S. Hara Y. Hirata Y, Marumo F, Sasaki S: Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 1993:361:549-552.
15. Decn PMT. Verdijk MAJ. Knoers NVAM. Wicringa B. Monnens LAH. van Os CH. van Oost BA: Requirement of human renal water channel aquaporin-2 for vasopressin-depen-dent concentration of urine. Science 1994:264: 92-95.
16. van Lieburg AF. Verdijk MAJ. Knoers VVAM. van Essen AJ. Proesmans W. Mallmann R. Monnens LAH. van Oost BA. van Os CH. Decn PMT: Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water channel gene. Am J Hum Genet 1994; in press.
17. Van Lieburg AF. Verdijk MAJ, Schoute F, Lig-tenberg MJL, van Oost BA. Waldhauser F. Dobner M. Monnens LAH. Knoers NVAM: Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 1995;96:70-78.
18. Brown RM. Fraser NJ, Brown GK: Differential méthylation of the hypervariable locus DXS255 on active and inactive X-chromo-somes correlates with the expression of a human X-linkcd gene. Genomics 1990;7:215-221.
19. Moses AM. Miller JL. Levine MA: Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab 1988:66:1259-1264.